nodes	percent_of_prediction	percent_of_DWPC	metapath
Rufinamide—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.0158	0.098	CcSEcCtD
Rufinamide—GRM5—endocrine gland—polycystic ovary syndrome	0.0131	0.0609	CbGeAlD
Rufinamide—CYP2E1—urine—polycystic ovary syndrome	0.0128	0.0595	CbGeAlD
Rufinamide—Contusion—Metformin—polycystic ovary syndrome	0.0107	0.0661	CcSEcCtD
Rufinamide—SCN7A—adipose tissue—polycystic ovary syndrome	0.0107	0.0494	CbGeAlD
Rufinamide—CYP3A4—urine—polycystic ovary syndrome	0.0103	0.0479	CbGeAlD
Rufinamide—SCN7A—adrenal gland—polycystic ovary syndrome	0.00957	0.0443	CbGeAlD
Rufinamide—SCN7A—female gonad—polycystic ovary syndrome	0.00892	0.0413	CbGeAlD
Rufinamide—SCN9A—pituitary gland—polycystic ovary syndrome	0.00839	0.0389	CbGeAlD
Rufinamide—SCN9A—adipose tissue—polycystic ovary syndrome	0.00836	0.0387	CbGeAlD
Rufinamide—SCN7A—endocrine gland—polycystic ovary syndrome	0.0083	0.0384	CbGeAlD
Rufinamide—SCN9A—adrenal gland—polycystic ovary syndrome	0.0075	0.0347	CbGeAlD
Rufinamide—SCN4A—pituitary gland—polycystic ovary syndrome	0.00748	0.0347	CbGeAlD
Rufinamide—SCN4A—adipose tissue—polycystic ovary syndrome	0.00745	0.0345	CbGeAlD
Rufinamide—SCN8A—endocrine gland—polycystic ovary syndrome	0.0074	0.0343	CbGeAlD
Rufinamide—SCN4A—adrenal gland—polycystic ovary syndrome	0.00669	0.031	CbGeAlD
Rufinamide—CES1—adipose tissue—polycystic ovary syndrome	0.00666	0.0308	CbGeAlD
Rufinamide—SCN2A—pituitary gland—polycystic ovary syndrome	0.00662	0.0307	CbGeAlD
Rufinamide—SCN10A—pituitary gland—polycystic ovary syndrome	0.00639	0.0296	CbGeAlD
Rufinamide—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00617	0.0382	CcSEcCtD
Rufinamide—Breast disorder—Metformin—polycystic ovary syndrome	0.00611	0.0378	CcSEcCtD
Rufinamide—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00604	0.0374	CcSEcCtD
Rufinamide—CES1—adrenal gland—polycystic ovary syndrome	0.00597	0.0277	CbGeAlD
Rufinamide—Influenza—Metformin—polycystic ovary syndrome	0.00584	0.0362	CcSEcCtD
Rufinamide—SCN3A—pituitary gland—polycystic ovary syndrome	0.00582	0.027	CbGeAlD
Rufinamide—SCN3A—adipose tissue—polycystic ovary syndrome	0.0058	0.0269	CbGeAlD
Rufinamide—CES1—female gonad—polycystic ovary syndrome	0.00557	0.0258	CbGeAlD
Rufinamide—SCN2A—vagina—polycystic ovary syndrome	0.00548	0.0254	CbGeAlD
Rufinamide—Neutropenia—Metformin—polycystic ovary syndrome	0.00546	0.0338	CcSEcCtD
Rufinamide—Infestation NOS—Metformin—polycystic ovary syndrome	0.00521	0.0322	CcSEcCtD
Rufinamide—Infestation—Metformin—polycystic ovary syndrome	0.00521	0.0322	CcSEcCtD
Rufinamide—SCN3A—adrenal gland—polycystic ovary syndrome	0.0052	0.0241	CbGeAlD
Rufinamide—CES1—endocrine gland—polycystic ovary syndrome	0.00518	0.024	CbGeAlD
Rufinamide—SCN2A—endocrine gland—polycystic ovary syndrome	0.00513	0.0238	CbGeAlD
Rufinamide—SCN10A—endocrine gland—polycystic ovary syndrome	0.00495	0.0229	CbGeAlD
Rufinamide—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00493	0.0305	CcSEcCtD
Rufinamide—SCN3A—vagina—polycystic ovary syndrome	0.00482	0.0223	CbGeAlD
Rufinamide—SCN5A—vagina—polycystic ovary syndrome	0.00481	0.0223	CbGeAlD
Rufinamide—Rhinitis—Metformin—polycystic ovary syndrome	0.00469	0.029	CcSEcCtD
Rufinamide—Eye disorder—Metformin—polycystic ovary syndrome	0.00437	0.027	CcSEcCtD
Rufinamide—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00434	0.0269	CcSEcCtD
Rufinamide—Immune system disorder—Metformin—polycystic ovary syndrome	0.00422	0.0261	CcSEcCtD
Rufinamide—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00421	0.0261	CcSEcCtD
Rufinamide—ALB—adrenal gland—polycystic ovary syndrome	0.00415	0.0192	CbGeAlD
Rufinamide—Malnutrition—Metformin—polycystic ovary syndrome	0.00407	0.0252	CcSEcCtD
Rufinamide—Vision blurred—Metformin—polycystic ovary syndrome	0.00384	0.0237	CcSEcCtD
Rufinamide—Tremor—Metformin—polycystic ovary syndrome	0.00381	0.0236	CcSEcCtD
Rufinamide—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00344	0.0213	CcSEcCtD
Rufinamide—Infection—Metformin—polycystic ovary syndrome	0.0033	0.0204	CcSEcCtD
Rufinamide—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00326	0.0202	CcSEcCtD
Rufinamide—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00325	0.0201	CcSEcCtD
Rufinamide—Skin disorder—Metformin—polycystic ovary syndrome	0.00323	0.02	CcSEcCtD
Rufinamide—Anorexia—Metformin—polycystic ovary syndrome	0.00317	0.0196	CcSEcCtD
Rufinamide—Somnolence—Metformin—polycystic ovary syndrome	0.00295	0.0183	CcSEcCtD
Rufinamide—Dyspepsia—Metformin—polycystic ovary syndrome	0.00292	0.0181	CcSEcCtD
Rufinamide—Decreased appetite—Metformin—polycystic ovary syndrome	0.00289	0.0179	CcSEcCtD
Rufinamide—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00287	0.0178	CcSEcCtD
Rufinamide—Fatigue—Metformin—polycystic ovary syndrome	0.00286	0.0177	CcSEcCtD
Rufinamide—Constipation—Metformin—polycystic ovary syndrome	0.00284	0.0176	CcSEcCtD
Rufinamide—CYP2E1—adrenal gland—polycystic ovary syndrome	0.00246	0.0114	CbGeAlD
Rufinamide—Asthenia—Metformin—polycystic ovary syndrome	0.00238	0.0148	CcSEcCtD
Rufinamide—Pruritus—Metformin—polycystic ovary syndrome	0.00235	0.0145	CcSEcCtD
Rufinamide—Diarrhoea—Metformin—polycystic ovary syndrome	0.00227	0.0141	CcSEcCtD
Rufinamide—Dizziness—Metformin—polycystic ovary syndrome	0.0022	0.0136	CcSEcCtD
Rufinamide—CYP2E1—endocrine gland—polycystic ovary syndrome	0.00213	0.00987	CbGeAlD
Rufinamide—Vomiting—Metformin—polycystic ovary syndrome	0.00211	0.0131	CcSEcCtD
Rufinamide—Rash—Metformin—polycystic ovary syndrome	0.00209	0.013	CcSEcCtD
Rufinamide—Dermatitis—Metformin—polycystic ovary syndrome	0.00209	0.013	CcSEcCtD
Rufinamide—Headache—Metformin—polycystic ovary syndrome	0.00208	0.0129	CcSEcCtD
Rufinamide—Nausea—Metformin—polycystic ovary syndrome	0.00197	0.0122	CcSEcCtD
Rufinamide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00171	0.00794	CbGeAlD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000316	0.000508	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000316	0.000508	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000316	0.000507	CbGpPWpGaD
Rufinamide—CYP2E1—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000315	0.000507	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—LEP—polycystic ovary syndrome	0.000312	0.000501	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—LEP—polycystic ovary syndrome	0.000312	0.000501	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000308	0.000495	CbGpPWpGaD
Rufinamide—GRM5—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000307	0.000492	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000306	0.000492	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SCNN1A—polycystic ovary syndrome	0.000301	0.000483	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—INS—polycystic ovary syndrome	0.000301	0.000483	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000297	0.000478	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000293	0.000471	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—IGF1—polycystic ovary syndrome	0.000293	0.000471	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000291	0.000468	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000291	0.000467	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00029	0.000465	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—PRL—polycystic ovary syndrome	0.000289	0.000464	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000288	0.000463	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—INS—polycystic ovary syndrome	0.000287	0.000462	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000282	0.000452	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000282	0.000452	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.000281	0.000451	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000279	0.000449	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—polycystic ovary syndrome	0.000279	0.000448	CbGpPWpGaD
Rufinamide—SCN7A—Axon guidance—IL6—polycystic ovary syndrome	0.000279	0.000448	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000278	0.000447	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—SERPINE1—polycystic ovary syndrome	0.000278	0.000447	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000278	0.000446	CbGpPWpGaD
Rufinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000278	0.000446	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—INS—polycystic ovary syndrome	0.000276	0.000444	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—INS—polycystic ovary syndrome	0.000276	0.000444	CbGpPWpGaD
Rufinamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000274	0.00044	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000274	0.00044	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000272	0.000436	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000272	0.000436	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000267	0.000429	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000267	0.000429	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000266	0.000428	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—INS—polycystic ovary syndrome	0.000266	0.000428	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—INS—polycystic ovary syndrome	0.000266	0.000428	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000266	0.000427	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—polycystic ovary syndrome	0.000265	0.000426	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000265	0.000426	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000258	0.000414	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000258	0.000414	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PDE3B—polycystic ovary syndrome	0.000258	0.000414	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000257	0.000414	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000257	0.000414	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000257	0.000412	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000255	0.000409	CbGpPWpGaD
Rufinamide—CYP2E1—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000254	0.000408	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000254	0.000408	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000251	0.000404	CbGpPWpGaD
Rufinamide—SCN11A—Axon guidance—IL6—polycystic ovary syndrome	0.000249	0.0004	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000245	0.000393	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000245	0.000393	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000244	0.000392	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000242	0.000389	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00024	0.000385	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000238	0.000382	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000236	0.000379	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000236	0.000379	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000235	0.000377	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000228	0.000366	CbGpPWpGaD
Rufinamide—SCN8A—Axon guidance—IL6—polycystic ovary syndrome	0.000228	0.000366	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000227	0.000364	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000225	0.000362	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000225	0.000361	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—RACGAP1—polycystic ovary syndrome	0.000221	0.000354	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—LEP—polycystic ovary syndrome	0.000219	0.000352	CbGpPWpGaD
Rufinamide—ALB—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.00021	0.000337	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000207	0.000333	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SUOX—polycystic ovary syndrome	0.000207	0.000333	CbGpPWpGaD
Rufinamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000207	0.000333	CbGpPWpGaD
Rufinamide—SCN5A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000206	0.00033	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000204	0.000327	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000203	0.000327	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000202	0.000324	CbGpPWpGaD
Rufinamide—SCN7A—Developmental Biology—IL6—polycystic ovary syndrome	0.000199	0.00032	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—LEP—polycystic ovary syndrome	0.000199	0.00032	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000199	0.000319	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NMNAT3—polycystic ovary syndrome	0.000195	0.000313	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000193	0.00031	CbGpPWpGaD
Rufinamide—CYP2E1—Biological oxidations—POMC—polycystic ovary syndrome	0.000192	0.000309	CbGpPWpGaD
Rufinamide—ALB—Platelet degranulation—VEGFA—polycystic ovary syndrome	0.000191	0.000308	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000191	0.000307	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.00019	0.000305	CbGpPWpGaD
Rufinamide—ALB—Vitamin B12 Metabolism—IL6—polycystic ovary syndrome	0.00019	0.000305	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000188	0.000302	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000187	0.000301	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—INS—polycystic ovary syndrome	0.000187	0.000301	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000186	0.000299	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000185	0.000297	CbGpPWpGaD
Rufinamide—SCN9A—Axon guidance—IL6—polycystic ovary syndrome	0.000184	0.000296	CbGpPWpGaD
Rufinamide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—polycystic ovary syndrome	0.000182	0.000293	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000182	0.000292	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000182	0.000292	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000181	0.000291	CbGpPWpGaD
Rufinamide—ALB—Metabolism—LPCAT2—polycystic ovary syndrome	0.000178	0.000286	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SUOX—polycystic ovary syndrome	0.000178	0.000286	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000178	0.000285	CbGpPWpGaD
Rufinamide—SCN11A—Developmental Biology—IL6—polycystic ovary syndrome	0.000178	0.000285	CbGpPWpGaD
Rufinamide—SCN3A—Axon guidance—IL6—polycystic ovary syndrome	0.000176	0.000283	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000176	0.000283	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000175	0.00028	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000175	0.00028	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—POMC—polycystic ovary syndrome	0.000171	0.000275	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—INS—polycystic ovary syndrome	0.00017	0.000273	CbGpPWpGaD
Rufinamide—SCN2A—Axon guidance—IL6—polycystic ovary syndrome	0.000169	0.000272	CbGpPWpGaD
Rufinamide—SCN4A—Axon guidance—IL6—polycystic ovary syndrome	0.000169	0.000272	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000168	0.00027	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000168	0.00027	CbGpPWpGaD
Rufinamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000168	0.00027	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000166	0.000266	CbGpPWpGaD
Rufinamide—ALB—Metabolism—ISYNA1—polycystic ovary syndrome	0.000166	0.000266	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000165	0.000264	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000164	0.000264	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000164	0.000263	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TEAD2—polycystic ovary syndrome	0.000164	0.000263	CbGpPWpGaD
Rufinamide—SCN1A—Axon guidance—IL6—polycystic ovary syndrome	0.000163	0.000262	CbGpPWpGaD
Rufinamide—SCN10A—Axon guidance—IL6—polycystic ovary syndrome	0.000163	0.000262	CbGpPWpGaD
Rufinamide—SCN8A—Developmental Biology—IL6—polycystic ovary syndrome	0.000162	0.000261	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000162	0.00026	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000156	0.000251	CbGpPWpGaD
Rufinamide—ALB—Folate Metabolism—IL6—polycystic ovary syndrome	0.000154	0.000248	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000151	0.000243	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000148	0.000238	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000146	0.000235	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000143	0.00023	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKR1C2—polycystic ovary syndrome	0.000141	0.000226	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TEAD2—polycystic ovary syndrome	0.000141	0.000226	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000137	0.000221	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000135	0.000218	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—PLAT—polycystic ovary syndrome	0.000135	0.000217	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000133	0.000214	CbGpPWpGaD
Rufinamide—SCN9A—Developmental Biology—IL6—polycystic ovary syndrome	0.000131	0.000211	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SRD5A1—polycystic ovary syndrome	0.00013	0.000209	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	0.00013	0.000209	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	0.00013	0.000209	CbGpPWpGaD
Rufinamide—GRM5—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000126	0.000202	CbGpPWpGaD
Rufinamide—SCN3A—Developmental Biology—IL6—polycystic ovary syndrome	0.000126	0.000202	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000126	0.000202	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—STAR—polycystic ovary syndrome	0.000124	0.0002	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	0.000123	0.000198	CbGpPWpGaD
Rufinamide—ALB—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000123	0.000197	CbGpPWpGaD
Rufinamide—SCN2A—Developmental Biology—IL6—polycystic ovary syndrome	0.000121	0.000194	CbGpPWpGaD
Rufinamide—SCN4A—Developmental Biology—IL6—polycystic ovary syndrome	0.000121	0.000194	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.00012	0.000192	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000118	0.00019	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PNPLA2—polycystic ovary syndrome	0.000118	0.00019	CbGpPWpGaD
Rufinamide—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000118	0.000189	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000117	0.000187	CbGpPWpGaD
Rufinamide—SCN10A—Developmental Biology—IL6—polycystic ovary syndrome	0.000116	0.000187	CbGpPWpGaD
Rufinamide—SCN1A—Developmental Biology—IL6—polycystic ovary syndrome	0.000116	0.000187	CbGpPWpGaD
Rufinamide—SCN5A—Axon guidance—IL6—polycystic ovary syndrome	0.000115	0.000184	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	0.000112	0.00018	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HMMR—polycystic ovary syndrome	0.000111	0.000178	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000107	0.000173	CbGpPWpGaD
Rufinamide—ALB—Metabolism—STAR—polycystic ovary syndrome	0.000107	0.000171	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000107	0.000171	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HSD3B1—polycystic ovary syndrome	0.000106	0.00017	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000106	0.00017	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000105	0.000169	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—GNAS—polycystic ovary syndrome	0.000103	0.000166	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	9.63e-05	0.000155	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	9.62e-05	0.000155	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	9.62e-05	0.000155	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HMMR—polycystic ovary syndrome	9.52e-05	0.000153	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	9.41e-05	0.000151	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	9.12e-05	0.000146	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	9.08e-05	0.000146	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	8.97e-05	0.000144	CbGpPWpGaD
Rufinamide—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	8.96e-05	0.000144	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	8.94e-05	0.000144	CbGpPWpGaD
Rufinamide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	8.92e-05	0.000143	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.51e-05	0.000137	CbGpPWpGaD
Rufinamide—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	8.49e-05	0.000136	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	8.39e-05	0.000135	CbGpPWpGaD
Rufinamide—ALB—Metabolism—LHB—polycystic ovary syndrome	8.28e-05	0.000133	CbGpPWpGaD
Rufinamide—SCN5A—Developmental Biology—IL6—polycystic ovary syndrome	8.18e-05	0.000131	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	8.13e-05	0.000131	CbGpPWpGaD
Rufinamide—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	8.09e-05	0.00013	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	7.84e-05	0.000126	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	7.83e-05	0.000126	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	7.61e-05	0.000122	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	7.61e-05	0.000122	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	7.53e-05	0.000121	CbGpPWpGaD
Rufinamide—GRM5—Signaling Pathways—IL6—polycystic ovary syndrome	7.43e-05	0.000119	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	7.43e-05	0.000119	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	7.21e-05	0.000116	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	7.02e-05	0.000113	CbGpPWpGaD
Rufinamide—ALB—Metabolism—RRM2—polycystic ovary syndrome	6.98e-05	0.000112	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	6.91e-05	0.000111	CbGpPWpGaD
Rufinamide—ALB—Metabolism—YAP1—polycystic ovary syndrome	6.73e-05	0.000108	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—IGF1—polycystic ovary syndrome	6.7e-05	0.000108	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—AKT2—polycystic ovary syndrome	6.7e-05	0.000108	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NAMPT—polycystic ovary syndrome	6.47e-05	0.000104	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.43e-05	0.000103	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	6.39e-05	0.000103	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	6.37e-05	0.000102	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	6.36e-05	0.000102	CbGpPWpGaD
Rufinamide—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.34e-05	0.000102	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	6.04e-05	9.7e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	6.03e-05	9.69e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—TH—polycystic ovary syndrome	5.98e-05	9.6e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	5.94e-05	9.54e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	5.82e-05	9.34e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	5.76e-05	9.26e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	5.47e-05	8.78e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—TH—polycystic ovary syndrome	5.14e-05	8.25e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	5.14e-05	8.25e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	5e-05	8.03e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	4.9e-05	7.87e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	4.88e-05	7.84e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	4.7e-05	7.55e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	4.65e-05	7.47e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.47e-05	7.18e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	4.41e-05	7.08e-05	CbGpPWpGaD
Rufinamide—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	4.38e-05	7.03e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	4.37e-05	7.02e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.23e-05	6.79e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—GNAS—polycystic ovary syndrome	4.2e-05	6.74e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	4.11e-05	6.6e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—NCOR1—polycystic ovary syndrome	4e-05	6.42e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.89e-05	6.25e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	3.79e-05	6.09e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.77e-05	6.06e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.63e-05	5.84e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—MTHFR—polycystic ovary syndrome	3.53e-05	5.67e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.49e-05	5.61e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.45e-05	5.54e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	3.33e-05	5.35e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	3.29e-05	5.28e-05	CbGpPWpGaD
Rufinamide—CYP2E1—Metabolism—INS—polycystic ovary syndrome	3.27e-05	5.25e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.26e-05	5.23e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.21e-05	5.15e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—PPARG—polycystic ovary syndrome	2.86e-05	4.6e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—POMC—polycystic ovary syndrome	2.82e-05	4.54e-05	CbGpPWpGaD
Rufinamide—ALB—Metabolism—INS—polycystic ovary syndrome	2.81e-05	4.51e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.77e-05	4.46e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.7e-05	4.33e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.54e-05	4.08e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.26e-05	3.64e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.16e-05	3.47e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.05e-05	3.28e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.91e-05	3.06e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.55e-05	2.48e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.52e-05	2.45e-05	CbGpPWpGaD
Rufinamide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.52e-05	2.44e-05	CbGpPWpGaD
